Fougera Pharmaceuticals Inc.Melville, NY United States
Company Description
Fougera Pharmaceuticals (formerly Nycomed US) makes specialty medicines for North Americans. The company is focused on making and selling drugs for dermatological conditions. Its E. Fougera & Company division primarily makes generic topical steroids, antibiotics, and antifungals for both prescription and OTC markets, while the PharmaDerm unit develops, manufactures, and markets branded prescription dermatology products. Its smaller Savage Laboratories unit makes prescription topicals for the emergency care market. Fougera Pharmaceuticals is controlled by an investment group led by Nordic Capital; it separated from its former parent,
| 60 Baylis Rd. | Phone: 631-454-7677 | http://www.fougerapharmaceuticals.com |
| Melville, NY 11747 | Fax: 631-454-6389 | |
| United States |
Fougera Pharmaceuticals Inc. Rankings
Executives
| 33 executives listed for Fougera Pharmaceuticals Inc.'s Melville, NY location. | ||
| SVP Operations | Mark Fitch | |
|---|---|---|
| SVP Finance | Barry Lederman | |
| SVP and General Counsel | JosephLaRosa | |
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 880 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Fougera Pharmaceuticals Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
